[go: up one dir, main page]

RU97118265A - Hemostatic remedy of local action - Google Patents

Hemostatic remedy of local action

Info

Publication number
RU97118265A
RU97118265A RU97118265/14A RU97118265A RU97118265A RU 97118265 A RU97118265 A RU 97118265A RU 97118265/14 A RU97118265/14 A RU 97118265/14A RU 97118265 A RU97118265 A RU 97118265A RU 97118265 A RU97118265 A RU 97118265A
Authority
RU
Russia
Prior art keywords
metal salts
agent according
ammonium compound
hemostatic
hemostatic agent
Prior art date
Application number
RU97118265/14A
Other languages
Russian (ru)
Other versions
RU2142278C1 (en
Inventor
А.Г. Чухаджян
Г.А. Чухаджян
В.Р. Дедеян
Original Assignee
А.Г. Чухаджян
Filing date
Publication date
Application filed by А.Г. Чухаджян filed Critical А.Г. Чухаджян
Priority to RU97118265A priority Critical patent/RU2142278C1/en
Priority claimed from RU97118265A external-priority patent/RU2142278C1/en
Publication of RU97118265A publication Critical patent/RU97118265A/en
Application granted granted Critical
Publication of RU2142278C1 publication Critical patent/RU2142278C1/en

Links

Claims (5)

1. Гемостатическое средство местного действия, содержащее соли металлов, наполнители, отличающееся тем, что оно содержит одну или смесь солей металлов или их смесь с хлористым кальцием, четвертичное аммониевое соединение, растворенные в водной среде или в физиологическом растворе при следующем соотношении компонентов, вес.%:
Соли металлов - 2,5-50
Четвертичное аммониевое соединение - 0,025-5
Вода или физиологический раствор - Остальное
при этом соотношение солей металлов в смеси составляет от 9:1 до 1:9.1. Hemostatic means of local action, containing metal salts, fillers, characterized in that it contains one or a mixture of metal salts or their mixture with calcium chloride, a quaternary ammonium compound dissolved in an aqueous medium or in physiological solution in the following ratio of components, weight. %:
Metal salts - 2,5-50
Quaternary ammonium compound - 0.025-5
Water or saline - Else
the ratio of metal salts in the mixture is from 9: 1 to 1: 9. 2. Гемостатическое средство по п. 1, отличающееся тем, что оно дополнительно содержит водорастворимый биосовместный синтетический полимер в количестве не более 5 вес.%. 2. Hemostatic agent according to claim 1, characterized in that it additionally contains a water-soluble biologically compatible synthetic polymer in an amount of not more than 5 wt.%. 3. Гемостатическое средство по п. 1, отличающееся тем, что в качестве солей металлов используют AlCl36Н2O, FeCl36Н2O, CaCl2 • 7 Н2О, АСК (SO4)2 • 12 Н2O или ZnCl2 безводный с плавл. 295oС.3. Hemostatic agent according to claim 1, characterized in that AlCl 3 6H 2 O, FeCl 3 6H 2 O, CaCl 2 • 7 H 2 O, ASA (SO 4 ) 2 • 12 H 2 O or ZnCl 2 anhydrous with a melt. 295 o C. 4. Гемостатическое средство по п. 1, отличающееся тем, что в качестве четвертичного аммониевого соединения оно содержит 50%-ный водный раствор алкилдиметилбензиламмония хлорид с алкильными радикалами C10 E21 - C18 - H37, аммониевое соединение формулы R1 R2 R3 R4 N+X-, где R1, R2, R3, R4 алкильные, арильные, циклоалкильные, бензильные, гетероциклические, а Х и -Сl, Вr остатки различных органических и неорганических кислот.4. Hemostatic agent according to claim 1, characterized in that as a quaternary ammonium compound it contains a 50% aqueous solution of alkyl dimethyl benzyl ammonium chloride with alkyl radicals C 10 E 21 - C 18 - H 37 , ammonium compound of the formula R 1 R 2 R 3 R 4 N + X - , where R 1 , R 2 , R 3 , R 4 are alkyl, aryl, cycloalkyl, benzyl, heterocyclic, and X and -Cl, Br residues of various organic and inorganic acids. 5. Гемостатическое средство по п. 2, отличающееся тем, что водорастворимый биосовместимый синтетический полимер выбирают из группы: поливиниловый спирт, поливинилпирролидон, карбоксиметилцеллюлозы. 5. The hemostatic agent according to claim 2, wherein the water-soluble biocompatible synthetic polymer is selected from the group: polyvinyl alcohol, polyvinylpyrrolidone, carboxymethylcellulose.
RU97118265A 1997-10-31 1997-10-31 Hemostatic agent showing topical effect RU2142278C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97118265A RU2142278C1 (en) 1997-10-31 1997-10-31 Hemostatic agent showing topical effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97118265A RU2142278C1 (en) 1997-10-31 1997-10-31 Hemostatic agent showing topical effect

Publications (2)

Publication Number Publication Date
RU97118265A true RU97118265A (en) 1999-07-20
RU2142278C1 RU2142278C1 (en) 1999-12-10

Family

ID=20198699

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97118265A RU2142278C1 (en) 1997-10-31 1997-10-31 Hemostatic agent showing topical effect

Country Status (1)

Country Link
RU (1) RU2142278C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4163C1 (en) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Medicinal preparation in the form of gel for the prevention of postoperative complications

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2200583C1 (en) * 2002-03-26 2003-03-20 Белозерская Галина Геннадьевна Hemostatic bandage
WO2004000347A1 (en) * 2002-06-21 2003-12-31 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
US7478959B2 (en) 2002-09-05 2009-01-20 Colgate-Palmolive Company Oral care toothbrush
RU2501556C2 (en) * 2011-10-06 2013-12-20 Владимир Лазаревич Адамян Heamostatic match

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4163C1 (en) * 2010-12-23 2012-11-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Medicinal preparation in the form of gel for the prevention of postoperative complications

Similar Documents

Publication Publication Date Title
ATE76625T1 (en) STABILIZED HYDROGEN PEROXIDE SOLUTION.
GR880100532A (en) Thixotropic clay aqueous suspensions containing salt fatty acid stabilizer
EA199900935A1 (en) INDAZOLAMIDE COMPOUNDS AS SEROTONINERGIC AGENTS
RU93056600A (en) PHENOXY- AND PHENOXIALKYLPIPERIDINE COMPOUNDS AND ANTI-VIRUS COMPOSITION
BR8904420A (en) WATER FORMULATION, SEED DISINFECTING AGENT, SEED DISINFECTION PROCESS AND TREATED SEED
RU97118265A (en) Hemostatic remedy of local action
MX170920B (en) AQUEOUS THICKENING COMPOSITION FOR CLEANING TOILET BOXES
KR960007539A (en) Ortho-substituted benzoic acid derivatives
DE59510442D1 (en) Polyaspartic acid derivatives containing sulfonic acid groups, their use and preparation
DE69811427T2 (en) Ascorbic acid 2-phosphate zinc salt and process for its preparation
RU97108965A (en) CONTAINING THROMBINE INHIBITOR STORAGE STABLE WATER INFUSION FOR STORAGE
ATE251129T1 (en) DERIVATIVES OF AMINOALKANE SULPHONIC, PHOSPHONIC AND PHOSPHINIC ACIDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
EP0827690A3 (en) Sulphur-containing quaternary ammonium ionene polymers and their use as microbicides
ES2053900T3 (en) MICROBICIDES PREPARED FOR THE DISINFECTION OF DENTAL MOLDED BODIES.
DE3583407D1 (en) METHOD FOR PRODUCING BENZOTHIAZEPINE DERIVATIVES.
ES2147841T3 (en) DERIVATIVES OF PIRIDAZINONE.
EP0481370A3 (en) Use of phosphonic acid diglycidylesters as cross-linking agent in hydrogels
RU93044484A (en) MIXED PARTIAL SALT OF THE COPOLYMER AND DENTAL-PROTECTIVE STABILIZING COMPOSITIONS ON ITS BASIS THAT HAVE IMPROVED TASTE
DE69821745D1 (en) FORMATION OF SUPER ABSORBENT POLYMER
DE59104485D1 (en) Process for the preparation of ureidoperoxycarboxylic acids.
SE8800846L (en) OPTICALLY ACTIVE OXO-ISOINDOLIN DERIVATIVES
KR960040156A (en) Stabilizing composition of 3-isothiazolone aqueous solution and method for producing the same
JPS5495638A (en) Antifouling agent in water
ES8305385A1 (en) Antimicrobial water soluble polymer prepn.
RU97111365A (en) STABILIZER FOR POLYACRYLAMIDE AND POLYACRYLAMIDE COMPOSITION